Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
2
self-reported band not used
Founded
2019
7 years
Legal entities
None matched
Office countries
1
2 addresses
Funding rounds
None on record
Company type
Nonprofit
self-reported
Description
The Australian Epilepsy Project has established a new standard of care for epilepsy based on a newly developed, AI enabled, brain health platform that can shorten the journey from epilepsy diagnosis through to management by up to 15 years.
Over 250,000 Australians live with epilepsy, a devastating, misunderstood and often hidden condition. 1 in 10 Australians will have a seizure in their lifetime, 1 in 25 will be diagnosed with epilepsy. More than 50 million people live with epilepsy worldwide and 30% (15 million) cannot find suitable medication to manage their seizures. Epilepsy is the second most burdensome neurological condition after dementia and is estimated to cost $12.3 billion a year in public healthcare.
The platform is a national solution that already connects patients with over 160 neurologists across Australia, and translates over 30 years of Florey research in imaging, genetics and psychology into patient outcomes positively impacting the lives of many Australians living with or recently diagnosed with epilepsy.
Impact is focused on democratising access to advanced epilepsy diagnostics at scale including tests which are not widely available under the current standard of care. This includes advanced MRI, neuropsychological assessments, and genetic testing. This is significantly important for patients experiencing their first seizure and/or have been newly diagnosed with epilepsy. On average, it can take 15+ years for patients to find access to diagnostics available as part of the AEP, and usually after they have tried several treatments without success.
Epilepsy is just the beginning. The AEP is designed to be a platform model for brain healthcare and research. We need to understand genetic risks, structural make-up and functioning to identify causes and predict intervention outcomes. This is highly applicable to other brain health issues such as dementia, concussion, and mental health.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU245 Burgundy St; Heidelberg, Victoria 3084Primary
- AUMelbourne
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at Australian Epilepsy Project?
2 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does Australian Epilepsy Project have offices?
Two addresses on record, Australia only. Primary: 245 Burgundy St, Heidelberg, Victoria 3084.
Has Australian Epilepsy Project raised funding?
None linked to this brand.
Which companies are listed alongside Australian Epilepsy Project?
5 profiles list Australian Epilepsy Project as a peer — 76th percentile in Research Services. It lists ten peers of its own. Epilepsy Network Australia and Australian Women with Epilepsy list it back.